IMM Immupharma Plc

TIDMIMM

RNS Number : 7012F

Immupharma PLC

22 May 2017

22 MAY 2017

ImmuPharma PLC

("ImmuPharma" or the "Company")

NOTIFICATION OF FULL YEAR RESULTS

Date: 1 June 2017

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, confirms that it will be announcing its full year results for the year ended 31 December 2016 on Thursday 1 June 2017.

-Ends-

 
 For further information please 
  contact: 
                                          + 44 (0) 20 
   ImmuPharma plc (www.immupharma.org)     7152 4080 
   Tim McCarthy, Chairman 
   Lisa Baderoon, Head of Investor 
    Relations                             + 44 (0) 7721 
    Twitter: @immupharma                   413496 
 
 
    Northland Capital Partners Limited 
    (Joint Broker) 
    Patrick Claridge, David Hignell, 
    Corporate Finance                      +44 (0)20 3861 
    Rob Rees, Corporate Broking                      6625 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORKMGMKZLVGNZM

(END) Dow Jones Newswires

May 22, 2017 02:01 ET (06:01 GMT)

Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2024 to Apr 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2023 to Apr 2024